A previously healthy 52-year-old woman comes to the physician because of a 3-month history of chest pain on exertion. She takes no medications. Cardiopulmonary examination shows no abnormalities. Cardiac stress ECG shows inducible ST-segment depressions in the precordial leads that coincide with the patient's report of chest pain and resolve upon cessation of exercise. Pharmacotherapy with verapamil is initiated. This drug is most likely to have which of the following sets of effects? $$$ End-diastolic volume (EDV) %%% Blood pressure (BP) %%% Contractility %%% Heart rate (HR) $$$

No change no change no change no change

A 52-year-old man presents to the emergency department (ED) complaining of palpitations and lightheadedness for the last 30 minutes. He denies feeling pain or discomfort in his chest and is not short of breath. He does not have any known medical problems and does not take any medications regularly. He drinks 4–6 caffeinated drinks a day. The temperature is 36.8°C (98.2°F), the pulse rate is 150/min and slightly irregular, the blood pressure is 144/84 mm Hg, and the respiratory rate is 16/min. A focused examination of the cardiovascular and respiratory systems is unremarkable. An electrocardiogram is performed in the ED and the results are shown in the accompanying image. The ED physician prescribes a calcium channel blocking agent for his condition. Which of the following statements best describes the choice of verapamil over nifedipine in the treatment of this patient?

Verapamil slows atrioventricular conduction more effectively than nifedipine.

Verapamil does not have non-specific anti-adrenergic effects, unlike nifedipine.

Verapamil has fewer negative inotropic effects than nifedipine.

Verapamil is more effective in decreasing blood pressure than nifedipine.

Verapamil binds to the α2 subunit of the L-type calcium channel, while nifedipine binds to the α1 subunit of the L-type calcium channel.

A 65-year-old male with a history of hypertension presents to his primary care physician complaining of multiple episodes of chest pain, palpitations, and syncope. Episodes have occurred twice daily for the last week, and he is asymptomatic between episodes. Electrocardiogram reveals a narrow-complex supraventricular tachycardia. He is treated with diltiazem. In addition to its effects on cardiac myocytes, on which of the following channels and tissues would diltiazem also block depolarization?

L-type Ca channels in smooth muscle

L-type Ca channels in skeletal muscle

P-type Ca channels in Purkinje fibers

N-type Ca channels in the peripheral nervous system

Calcium channel blockers (dihydropyridine/non-dihydropyridine) for USMLE Step 1: High-Yield Pharmacology Lessons

Mechanism of Action - The Calcium Gatekeepers

Primary Target: Inhibit voltage-gated L-type calcium channels in vascular smooth muscle and cardiac cells.
Vascular Effect: ↓ intracellular $Ca^{2+}$ → smooth muscle relaxation → peripheral vasodilation → ↓ afterload.
Cardiac Effect: ↓ intracellular $Ca^{2+}$ → ↓ myocardial contractility (negative inotropy) & ↓ sinoatrial/atrioventricular node activity (negative chronotropy/dromotropy).

⭐ Dihydropyridines (e.g., amlodipine) are more selective for vascular smooth muscle, while non-dihydropyridines (verapamil, diltiazem) also exert significant effects on the heart.

Dihydropyridines vs. Non-dihydropyridines: Mechanism & Uses

Classification - Two Sides of the Channel

Calcium Channel Blockers (CCBs) are split into two major classes based on their primary site of action and chemical structure. This dictates their clinical use.

Dihydropyridines (DHPs):
- Act predominantly on arterial vascular smooth muscle.
- Potent vasodilators, leading to ↓ blood pressure.
- 📌 All generic names end in "-dipine".
Non-dihydropyridines (Non-DHPs):
- Greater effect on the myocardium.
- Act as negative inotropes (↓ contractility) and chronotropes (↓ heart rate).
- Verapamil has the strongest cardiac effect; Diltiazem is intermediate.

⭐ Because DHPs are potent vasodilators with minimal direct cardiac effect, they can cause a reflex tachycardia. This is a key physiological distinction from the bradycardic effect of non-DHPs.

Adverse Effects - The Unwanted Reactions

Dihydropyridines (Amlodipine, Nifedipine): Effects from potent vasodilation.
- Peripheral edema (ankles, pretibial)
- Flushing, headache, dizziness
- Reflex tachycardia
- Gingival hyperplasia
Non-Dihydropyridines (Verapamil, Diltiazem): Effects from cardiac suppression.
- Bradycardia & AV block (↑ PR interval)
- Worsening systolic heart failure (negative inotropy)
- Constipation (esp. Verapamil)
- Gingival hyperplasia

⭐ Dihydropyridine-induced edema results from precapillary arteriolar dilation, not fluid retention, and thus does not respond to diuretics.

CCB-induced edema & reduction with RAS inhibitor

Clinical Use - Choosing Your Blocker

Dihydropyridines (e.g., Amlodipine, Nifedipine): Primarily potent peripheral vasodilators.
- Ideal for: Isolated hypertension, Prinzmetal angina.
- Key side effects: Peripheral edema, reflex tachycardia, flushing.
Non-dihydropyridines (e.g., Verapamil, Diltiazem): Act on heart and blood vessels.
- Ideal for: Hypertension with co-existing atrial fibrillation (rate control), angina pectoris, migraine prophylaxis (Verapamil).
- ⚠️ Avoid in: HFrEF (Heart Failure with reduced Ejection Fraction) and AV block due to negative inotropic/chronotropic effects.

⭐ Nimodipine is a DHP that is highly lipid-soluble, crosses the blood-brain barrier, and is specifically used to prevent cerebral vasospasm after a subarachnoid hemorrhage.

High‑Yield Points - ⚡ Biggest Takeaways

Dihydropyridines (e.g., amlodipine) are potent arterial vasodilators, mainly for hypertension; watch for peripheral edema and reflex tachycardia.

Non-dihydropyridines (verapamil, diltiazem) act on the heart and blood vessels, treating hypertension, angina, and atrial fibrillation.

Verapamil has the strongest cardiac depressant effect (negative inotropy/chronotropy).

Key non-DHP side effects include constipation (especially verapamil), bradycardia, and AV block.

Gingival hyperplasia is a classic side effect for all CCBs.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play